Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males

PHASE2CompletedINTERVENTIONAL
Enrollment

149

Participants

Timeline

Start Date

June 28, 2011

Primary Completion Date

December 12, 2017

Study Completion Date

December 12, 2017

Conditions
Anal CancerNonneoplastic ConditionPenile CancerPrecancerous Condition
Interventions
BIOLOGICAL

quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine

OTHER

laboratory biomarker analysis

Trial Locations (19)

10010

Laser Surgery Care, New York

10461

Montefiore Medical Center, The Bronx

10467

Montefiore Medical Center, The Bronx

27157

Wake Forest University Health Sciences, Winston-Salem

38105

St. Jude's Children's Research Hospital, Memphis

60612

Ruth M. Rothstein Core Center at Cook County Hospital, Chicago

63110

Washington University School of Medicine, St Louis

77009

Thomas Street Health Center, Houston

77030

Dan L. Duncan Cancer Center at Baylor College of Medicine, Houston

80045

University of Colorado Cancer Center at UC Health Sciences Center, Aurora

90024

UCLA Clinical AIDS Research and Education (CARE) Center, Los Angeles

92093

Moores UCSD Cancer Center, La Jolla

94115

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco

98101

Virginia Mason Medical Center, Seattle

90027-0700

Childrens Hospital Los Angeles, Los Angeles

60612-9985

John H. Stroger, Jr. Hospital of Cook County, Chicago

02115

Fenway Community Health, Boston

02118

Boston University Cancer Research Center, Boston

00927

University of Puerto Rico Comprehensive Cancer Center, San Juan

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

The Emmes Company, LLC

INDUSTRY

collaborator

University of Arkansas

OTHER

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

collaborator

AIDS and Cancer Specimen Resource

OTHER

lead

AIDS Malignancy Consortium

NETWORK

NCT01209325 - Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males | Biotech Hunter | Biotech Hunter